title: Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review.
abstract: Ovarian cancer is the most lethal gynecologic malignancy; consequently, there is a need for effective therapies. Epothilones are microtubule-stabilizing agents that inhibit cell growth. Currently, patupilone and its four synthetic derivatives ixabepilone, BMS-310705, sagopilone, 20-desmethyl-20-methylsulfanyl epothilone B and epothilone D, as well as its derivative KOS-1584, are under clinical evaluation. This is the first systematic review conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines that synthesizes all available data emerging from trials and evaluates the efficacy and safety of epothilones in epithelial ovarian, primary fallopian tube, and primary peritoneal cancer. Despite the fact that epothilones have proven active in taxane-resistant settings in preclinical models, it is not yet clear from Phase II/III studies reviewed here that their clinical activity is superior to that of taxanes. Nevertheless, responses to epothilones have been observed in platinum-refractory/resistant ovarian cancer patients. Moreover, despite the shared mechanism of action of epothilones, their clinical profile seems clearly different, with diarrhea being the most common dose-limiting toxicity encountered with patupilone, whereas neutropenia and sensory neuropathy are the most common toxic effects observed with the other epothilones. In any case, randomized trials comparing epothilones with standard treatments seem warranted to define further the role of these agents, whereas biomarker analysis might further optimize patient selection.
authors: Department of Clinical Therapeutics, Alexandra Hospital, University of Athens, Athens, Greece.
authors: Flora
authors: F
authors: Zagouri
authors: First Propaedeutic Surgical Department, Hippokration Hospital, University of Athens, Athens, Greece.
authors: Theodoros N
authors: TN
authors: Sergentanis
authors: First Propaedeutic Surgical Department, Hippokration Hospital, University of Athens, Athens, Greece.
authors: Dimosthenis
authors: D
authors: Chrysikos
authors: Department of Clinical Therapeutics, Alexandra Hospital, University of Athens, Athens, Greece.
authors: Meletios-Athanassios
authors: MA
authors: Dimopoulos
authors: Department of Clinical Therapeutics, Alexandra Hospital, University of Athens, Athens, Greece.
authors: Aristotle
authors: A
authors: Bamias
keywords: epothilone; ixabepilone; ovarian cancer; patupilone; systematic review